Increased Wnt and Notch signaling: a clue to the renal disease in Schimke immuno-osseous dysplasia?

Marie Morimoto, Clara Myung, Kimberly Beirnes, Kunho Choi, Yumi Asakura, Arend Bokenkamp, Dominique Bonneau, Milena Brugnara, Joel Charrow, Estelle Colin, Amira Davis, Georges Deschenes, Mattia Gentile, Mario Giordano, Andrew K. Gormley, Rajeshree Govender, Mark Joseph, Kory Keller, Evelyne Lerut, Elena LevtchenkoLaura Massella, Christy Mayfield, Behzad Najafian, David Parham, Jurgen Spranger, Peter Stenzel, Uluc Yis, Zhongxin Yu, Jonathan Zonana, Glenda Hendson, Cornelius F. Boerkoel*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Background: Schimke immuno-osseous dysplasia (SIOD) is a multisystemic disorder caused by biallelic mutations in the SWI/SNF-related matrix-associated actin-dependent regulator of chromatin, subfamily A-like 1 (SMARCAL1) gene. Changes in gene expression underlie the arteriosclerosis and T-cell immunodeficiency of SIOD; therefore, we hypothesized that SMARCAL1 deficiency causes the focal segmental glomerulosclerosis (FSGS) of SIOD by altering renal gene expression. We tested this hypothesis by gene expression analysis of an SIOD patient kidney and verified these findings through immunofluorescent analysis in additional SIOD patients and a genetic interaction analysis in Drosophila. Results: We found increased expression of components and targets of the Wnt and Notch signaling pathways in the SIOD patient kidney, increased levels of unphosphorylated β-catenin and Notch1 intracellular domain in the glomeruli of most SIOD patient kidneys, and genetic interaction between the Drosophila SMARCAL1 homologue Marcal1 and genes of the Wnt and Notch signaling pathways. Conclusions: We conclude that increased Wnt and Notch activity result from SMARCAL1 deficiency and, as established causes of FSGS, contribute to the renal disease of most SIOD patients. This further clarifies the pathogenesis of SIOD and will hopefully direct potential therapeutic approaches for SIOD patients.

Original languageEnglish (US)
Pages (from-to)1-12
Number of pages12
JournalOrphanet journal of rare diseases
Volume11
Issue number1
DOIs
StatePublished - Nov 5 2016

Funding

This work was supported in part by the New Investigator Award jointly sponsored by the SickKids Foundation and the Canadian Institutes of Health Research Institute of Human Development, Child and Youth Health (XG09-025 to CFB); the Michael Smith Foundation for Health Research (CI-SCH-O1899(07\u2013 1) to CFB); The Little Giants Foundation (CFB); and the Asociacion Espa\u00F1ola de Displasias Oseas Minoritarias (CFB). Human fetal tissue was obtained through the Laboratory of Developmental Biology project supported by the National Institutes of Health Award Number 5R24HD000836 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. MM was supported by a Four Year Doctoral Fellowship from the University of British Columbia. CFB is a scholar of the Michael Smith Foundation for Health Research and a Clinical Investigator of the Child & Family Research Institute.

Keywords

  • Focal segmental glomerulosclerosis
  • Notch signaling pathway
  • SMARCAL1 protein
  • Schimke immuno-osseous dysplasia
  • Wnt signaling pathway

ASJC Scopus subject areas

  • Genetics(clinical)
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Increased Wnt and Notch signaling: a clue to the renal disease in Schimke immuno-osseous dysplasia?'. Together they form a unique fingerprint.

Cite this